LINC01011
gene geneOn this page
Also known as CISALDKFZp686I15217
Summary
LINC01011 (long intergenic non-protein coding RNA 1011, HGNC:33812) is a long non-coding RNA gene on chromosome 6p25.2.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33812 |
| Approved symbol | LINC01011 |
| Name | long intergenic non-protein coding RNA 1011 |
| Location | 6p25.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | CISAL, DKFZp686I15217 |
| Ensembl gene | ENSG00000244041 |
| Ensembl biotype | lncRNA |
| OMIM | 621279 |
| Entrez | 401232 |
| RNAcentral | URS000075DCAC — lncRNA, 1591 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 lncRNA
ENST00000445000, ENST00000450238, ENST00000454015, ENST00000605901
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000445000 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001595929 | 2988428 | 2991173 |
| ENSE00001697990 | 2987967 | 2988031 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 93.50.
FANTOM5 (CAGE): breadth broad, TPM avg 1.5957 / max 200.9506, expressed in 391 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 65499 | 1.6852 | 882 |
| 65498 | 1.2091 | 241 |
| 65500 | 0.3866 | 176 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thymus | UBERON:0002370 | 93.50 | silver quality |
| monocyte | CL:0000576 | 84.47 | gold quality |
| cerebellar vermis | UBERON:0004720 | 84.00 | gold quality |
| leukocyte | CL:0000738 | 83.63 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 81.20 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 81.20 | gold quality |
| cerebellum | UBERON:0002037 | 81.12 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.03 | silver quality |
| quadriceps femoris | UBERON:0001377 | 77.38 | gold quality |
| spinal cord | UBERON:0002240 | 77.33 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.28 | gold quality |
| substantia nigra | UBERON:0002038 | 77.13 | gold quality |
| primary visual cortex | UBERON:0002436 | 76.23 | gold quality |
| right uterine tube | UBERON:0001302 | 75.99 | gold quality |
| popliteal artery | UBERON:0002250 | 75.99 | gold quality |
| tibial artery | UBERON:0007610 | 75.97 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 75.90 | gold quality |
| right frontal lobe | UBERON:0002810 | 75.79 | gold quality |
| right coronary artery | UBERON:0001625 | 75.74 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 75.72 | gold quality |
| Ammon’s horn | UBERON:0001954 | 75.63 | gold quality |
| amygdala | UBERON:0001876 | 75.50 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 75.45 | gold quality |
| temporal lobe | UBERON:0001871 | 75.41 | gold quality |
| blood | UBERON:0000178 | 75.37 | gold quality |
| brain | UBERON:0000955 | 75.37 | gold quality |
| hypothalamus | UBERON:0001898 | 75.22 | gold quality |
| cortical plate | UBERON:0005343 | 75.08 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.66 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.